Y-mAbs Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Y-mAbs Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $2.64 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-08-08
- 2025-06-30: Operating Lease, Liability, Noncurrent $2.64M.
- 2025-03-31: Operating Lease, Liability, Noncurrent $148.00K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $190.00K.
- 2024-09-30: Operating Lease, Liability, Noncurrent $299.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $2.64M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $148.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $190.00K 10-Q · filed 2025-08-08 |
| 2024-09-30 | $299.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $432.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $293.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $517.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $725.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $416.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $629.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $899.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.02M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.30M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.60M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.85M 10-K · filed 2023-03-30 |
| 2021-09-30 | $654.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $988.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.51M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.01M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.52M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.40M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.54M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.71M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.82M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $1.98M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.13M 10-Q · filed 2019-05-10 |